TBX21 and liver cancer: The detection of conventional and Tbet+ Treg populations in OPSCC and CxCa confirmed studies reporting the presence of CD4+Foxp3+ T cells co-expressing Tbet in chronic hepatitis C driven liver cancer, oral squamous cell carcinoma and ovarian cancer [28–30].